Document Detail

18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters.
MedLine Citation:
PMID:  21385914     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To investigate the diagnostic performance of (18)F-fludeoxyglucose ((18)F-FDG) positron emission tomography (PET)/CT in patients with suspected large-vessel vasculitis and its potential to evaluate the extent and activity of disease.
METHODS: 78 consecutive patients (mean age 63 years; 53 females) with suspected large-vessel vasculitis were evaluated with (18)F-FDG PET/CT.( 18)F-FDG uptake in the aorta and major branches was visually graded using a four-point scale and quantified with standardised uptake values (SUV(max)). According to clinical diagnosis, patients were classified into three groups: (a) steroid-naïve, large-vessel vasculitis (16 patients), (b) vasculitis on steroid treatment (18 patients) and (c) no evidence of vasculitis (44 patients). Analysis of variance and linear regression were used to investigate the association of (18)F-FDG uptake with clinical diagnosis and inflammatory markers.
RESULTS: (18)F-FDG PET/CT was positive (visual uptake ≥ 2; equal to or greater than liver) in all patients with steroid-naïve, large-vessel vasculitis. The thoracic aorta, the carotid and the subclavian arteries were most frequently involved. In these patients, SUV(max) values were significantly higher than in the other groups (analysis of variance; p<0.05). Linear regression showed a significant positive association (b-coefficients: 0.018-0.02; p<0.05) between SUV(max) of the thoracic aorta and inflammatory markers in patients with vasculitis (Groups a and b). Patients on steroid treatment showed low visual scores (uptake <2) and significantly lower SUV(max) values than steroid-naïve patients.
CONCLUSION: (18)F-FDG PET/CT can detect the extent and activity of large-vessel vasculitis in untreated patients and is unreliable in diagnosing vasculitis in patients on steroids.
N D Papathanasiou; Y Du; L J Menezes; A Almuhaideb; M Shastry; H Beynon; J B Bomanji
Related Documents :
10511034 - Conjunctival deposits as an initial manifestation of sarcoidosis.
16236934 - Qt dispersion in sarcoidosis.
16496264 - Conjunctival deposits as the first sign of systemic sarcoidosis in a pediatric patient.
6932004 - Lingual cortical mandibular defects: a radiographic incidence study.
21883674 - Discrimination between copd with and without alpha 1-antitrypsin deficiency using an el...
20396664 - Gastric mucosal changes caused by lugol's iodine solution spray: endoscopic features of...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-03-08
Journal Detail:
Title:  The British journal of radiology     Volume:  85     ISSN:  1748-880X     ISO Abbreviation:  Br J Radiol     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-05     Completed Date:  2012-08-06     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  0373125     Medline TA:  Br J Radiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  e188-94     Citation Subset:  AIM; IM    
Institute of Nuclear Medicine, University College Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fluorodeoxyglucose F18 / diagnostic use*
Middle Aged
Positron-Emission Tomography and Computed Tomography*
Radiopharmaceuticals / diagnostic use*
Retrospective Studies
Vasculitis / blood,  radionuclide imaging*
Grant Support
//Department of Health
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Time-resolved MR angiography for detecting and grading ovarian venous reflux: comparison with conven...
Next Document:  Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer:...